These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6435484)

  • 21. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu W
    Lancet; 1984 Jun; 1(8389):1297. PubMed ID: 6145002
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of various cutaneously administered nitroglycerin preparations on coronary heart disease].
    Zeiher A; Drexler H; Bonzel T; Wollschläger H; Hust MH; Löllgen H; Just H
    Schweiz Med Wochenschr Suppl; 1984; 16():70-6. PubMed ID: 6429852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of transdermal nitroglycerin therapy with previous long-acting oral or ointment nitrate therapy.
    Chinoy DA
    Clin Ther; 1987; 9(5):466-73. PubMed ID: 3117368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Taylor SH
    Lancet; 1984 Jul; 2(8394):97. PubMed ID: 6146027
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitroglycerin in a transdermal therapeutic system in chronic heart failure.
    Sharpe DN; Coxon R
    J Cardiovasc Pharmacol; 1984; 6(1):76-82. PubMed ID: 6199616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised study comparing systemic transdermal treatment and local application of glyceryl trinitrate ointment in the management of chronic anal fissure.
    Colak T; Ipek T; Urkaya N; Kanik A; Dirlik M
    Eur J Surg Suppl; 2003 Jul; (588):18-22. PubMed ID: 15200038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma concentration of cutaneously applied trinitroglycerin.
    Magometschnigg D; Horwatitsch H; Pichler M
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):178-82. PubMed ID: 6408014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified-release ointment with nitroglycerin β-cyclodextrin inclusion complex for treatment of anal fissures.
    Centkowska K; Sznitowska M
    J Pharm Pharmacol; 2013 Oct; 65(10):1463-72. PubMed ID: 24028613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of nitroglycerin ointments in the rabbit.
    Ritschel WA; Ritschel-Beurlin G; Grummich K
    Arzneimittelforschung; 1980; 30(3):432-5. PubMed ID: 6770874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma nitroglycerin levels, blood pressure and apical heart rate variations to site of application of nitroglycerin ointment.
    Conant CC
    Nurse Pract; 1988 Oct; 13(10):56, 58, 63-4. PubMed ID: 3147433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulatory counter-regulations induced by continuous administration of nitroglycerin.
    Imhof PR; Rennwald D; Müller P; Howald H; Burkart F
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):409-14. PubMed ID: 2501598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure.
    Moe G; Armstrong PW
    Am J Med; 1986 Nov; 81(5):765-70. PubMed ID: 3096133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitroglycerin ointment: a review.
    Francis GS; Hagan AD
    Angiology; 1977 Dec; 28(12):873-8. PubMed ID: 414640
    [No Abstract]   [Full Text] [Related]  

  • 35. Human pharmacological studies of a new transdermal system containing nitroglycerin.
    Müller P; Imhof PR; Burkart F; Chu LC; Gérardin A
    Eur J Clin Pharmacol; 1982; 22(6):473-80. PubMed ID: 6813125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nitroglycerin polymer gel matrix system: a new method for administering nitroglycerin evaluated with plasma nitroglycerin levels.
    Colfer H; Stetson P; Lucchesi BR; Wagner J; Pitt B
    J Cardiovasc Pharmacol; 1982; 4(3):521-5. PubMed ID: 6177952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration.
    Noonan PK; Benet LZ
    Clin Pharmacol Ther; 1987 Sep; 42(3):273-7. PubMed ID: 3113806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of atenolol and nitroglycerin ointment on exertion tolerance in coronary disease].
    Koenig W; Diehm C
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1798-803. PubMed ID: 6416805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical nitroglycerin ointment for treatment of acute hypertension in hospitalized inpatients.
    Brower KA; Garcia NA; Smith HL; Wall GC
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):284-8. PubMed ID: 25193736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitroglycerin absorption from transdermal systems: formulation effects and metabolite concentrations.
    Williams RL; Thakker KM; John V; Lin ET; Liang-Gee W; Benet LZ
    Pharm Res; 1991 Jun; 8(6):744-9. PubMed ID: 1905809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.